No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
FIHL Fidelis Insurance
- 18.890
- +0.200+1.07%
Close May 6 16:00 ET
2.22BMarket Cap1.04P/E (TTM)
19.015High18.700Low248.17KVolume18.860Open18.690Pre Close4.68MTurnover0.52%Turnover Ratio1.04P/E (Static)117.67MShares20.53052wk High0.91P/B899.16MFloat Cap11.48752wk Low--Dividend TTM47.60MShs Float20.530Historical High--Div YieldTTM1.69%Amplitude11.487Historical Low18.850Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Shares of Stocks Within the Broader Financial Sector Are Trading Lower Following Earlier Economic Data. Also, the Sector May Be Moving Ahead of the Upcoming Fed Decision
Express News | JMP Securities Reiterates Market Outperform on Fidelis Insurance Hldgs, Maintains $24 Price Target
Express News | Fidelis Insurance Holdings Ltd : Citigroup Raises Target Price to $22 From $21
Express News | Keefe, Bruyette & Woods Maintains Outperform on Fidelis Insurance Hldgs, Raises Price Target to $24
Lemonade (LMND) Expands in France With Homeowners Insurance
Why Fidelis Insurance Holdings Limited Rallied 30.2% in March
Comments
Despite strong revenue, the P/S ratio remains stagnant, possibly due to anticipated slowdown in growth. The high P/S ratio and forecasted revenue decline may impact the share price negatively. Investors might be overpaying given the revenue outlook.
Fidelis Insurance Holdings Limited (NYSE:FIHL) Stock Rockets 32% As Investors Are Less Pessimistic Than ExpectedCEO Dan Burrows expressed confidence in the company's ability to continue to lean into profitable growth opportunities and optimize shareholder value creation, reflecting the company's balance sheet strength following a transformative year.
1
Despite strong past growth, anticipated revenue slump amid industry growth puts the company in a less favorable light. Lower P/S may occur if top-line growth does not improve.
$T2 Biosystems(TTOO.US$ buy the dip $EBET Inc(EBET.US$ $Virgin Galactic(SPCE.US$ $Avalo Therapeutics(AVTX.US$ $MIND Technology(MIND.US$ $Canoo(GOEV.US$ $Mullen Automotive(MULN.US$ $Cybin(CYBN.US$ $Biocept(BIOC.US$ $Novo Integrated Sciences(NVOS.US$ $BullFrog AI(BFRG.US$ $Axcella Health(AXLA.US$ $BioNTech(BNTX.US$ $Nikola(NKLA.US$ $WeWork(WE.US$ $Ault Alliance(AULT.US$ $Acer Therapeutics(ACER.US$ $Rite Aid(RAD.US$ $CVS Health(CVS.US$ $Fidelis Insurance(FIHL.US$ $MEDICAL MARIJUANA INC(MJNA.US$
7
3
MACRO
US First-Quarter Growth Revised Up to 2% on Exports, Consumers
US gross domestic product was revised up notably to a 2% annualized advance in the first quarter, data showed Thursday.
The government's third estimate of GDP for the period reflected upward revisions to exports and consumer spending. Household spending, the engine of the US economy, rose at a 4.2% pace — the strongest in nearly two years — as ...
US First-Quarter Growth Revised Up to 2% on Exports, Consumers
US gross domestic product was revised up notably to a 2% annualized advance in the first quarter, data showed Thursday.
The government's third estimate of GDP for the period reflected upward revisions to exports and consumer spending. Household spending, the engine of the US economy, rose at a 4.2% pace — the strongest in nearly two years — as ...
+3
13
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg